The DOI matches its Crossref record; 46 of the 47 references it cites were found in a registry or an index.
High-Throughput Screening of a Collection of Known Pharmacologically Active Small Compounds for Identification of Candida albicans Biofilm Inhibitors
Open accessAbstract
Candida albicans is the most common etiologic agent of systemic fungal infections with unacceptably high mortality rates. The existing arsenal of antifungal drugs is very limited and is particularly ineffective against C. albicans biofilms. To address the unmet need for novel antifungals, particularly those active against biofilms, we have screened a small molecule library consisting of 1,200 off-patent drugs already approved by the Food and Drug Administration (FDA), the Prestwick Chemical Library, to identify inhibitors of C. albicans biofilm formation. According to their pharmacological applications that are currently known, we classified these bioactive compounds as antifungal drugs, as antimicrobials/antiseptics, or as miscellaneous drugs, which we considered to be drugs with no previously characterized antifungal activity. Using a 96-well microtiter plate-based high-content screening assay, we identified 38 pharmacologically active agents that inhibit C. albicans biofilm formation. These drugs were subsequently tested for their potency and efficacy against preformed biofilms, and we identified three drugs with novel antifungal activity. Thus, repurposing FDA-approved drugs opens up a valuable new avenue for identification and potentially rapid development of antifungal agents, which are urgently needed.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“| Zotepine | | | | | | (High affinity to dopamine | | | | | | receptors, affects serotonin receptors, its active metabolite, | C. albicans | 0.1-40 µM (0.03-12 µg/mL) | Inhibits biofilm development | [10] |”
From Antimicrobial Properties of Antidepressants and Antipsychotics—Possibilities and Implications (2021) · cites this paper as [10]
Citations
Cites
Biofilms: Survival Mechanisms of Clinically Relevant Microorganisms
Donlan, R. M., & Costerton, J. W. (2002) · Clinical Microbiology Reviews · doi:10.1128/cmr.15.2.167-193.2002 · Cited by 6,644
Gillum, A. M., Tsay, E. Y. H., & Kirsch, D. R. (1984) · Molecular and General Genetics MGG · doi:10.1007/bf00328721 · Cited by 1,253
Antifungal agents: mechanisms of action
Odds, F. C., Brown, A. J. P., & Gow, N. A. R. (2003) · Trends in Microbiology · doi:10.1016/s0966-842x(03)00117-3 · Cited by 1,202
Candida biofilms and their role in infection
Douglas, L. J. (2003) · Trends in Microbiology · doi:10.1016/s0966-842x(02)00002-1 · Cited by 1,150
Attributable Mortality of Nosocomial Candidemia, Revisited
Gudlaugsson, O., Gillespie, S., Lee, K., Berg, J. V., Hu, J., Messer, S., Herwaldt, L., Pfaller, M., & Diekema, D. (2003) · Clinical Infectious Diseases · doi:10.1086/378745 · Cited by 1,140
Current and emerging azole antifungal agents
Sheehan, D. J., Hitchcock, C. A., & Sibley, C. M. (1999) · Clinical Microbiology Reviews · doi:10.1128/cmr.12.1.40 · Cited by 1,137
Candida Infections of Medical Devices
Kojic, E. M., & Darouiche, R. O. (2004) · Clinical Microbiology Reviews · doi:10.1128/cmr.17.2.255-267.2004 · Cited by 1,055
Pierce, C. G., Uppuluri, P., Tristan, A. R., Wormley, F. L., Mowat, E., Ramage, G., & Lopez-Ribot, J. L. (2008) · Nature Protocols · doi:10.1038/nprot.2008.141 · Cited by 1,041
Self-citationCalderone, R. (2012) · ASM Press eBooks · Cited by 912
Kuhn, D. M., George, T., Chandra, J., Mukherjee, P. K., & Ghannoum, M. A. (2002) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.46.6.1773-1780.2002 · Cited by 775
Flagged first, then by citations
1 of the 47 references couldn’t be matched to a known paper.
Cited by
Sorted by citations
Items 101–120 of 120
Reen, F. J. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-809633-8.90261-9 · Cited by 2
Antifungal effects of alantolactone on Candida albicans: an in vitro studyPreprint
Liu, X., Zhong, L., Ma, Z., Sui, Y., Xie, J., Ma, T., & Yang, L. (2021) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2021.01.25.428193 · Cited by 2
Pierce, C. G., Srinivasan, A., Uppuluri, P., Ramasubramanian, A. K., & Lopez-Ribot, J. L. (2014) · Springer series on biofilms · doi:10.1007/978-3-642-53833-9_13 · Cited by 1
Self-citationClinical Implications of Candida Biofilms
Bernardo, S. M., Ilieva, V. P., Walraven, C. J., & Lee, S. A. (2017) · Current Fungal Infection Reports · doi:10.1007/s12281-017-0302-9 · Cited by 3
Drug Repurposing and Virtual Screening
Sharma, R., Roy, S., & Kumar, A. (2025) · Springer eBooks · doi:10.1007/978-981-97-9230-6_16 · Cited by 1
Tena‐Garitaonaindia, M., Ceacero‐Heras, D., Montoro, M. D. M. M., de Medina, F. S., Martínez‐Augustin, O., & Daddaoua, A. (2022) · Frontiers in Microbiology · doi:10.3389/fmicb.2022.814448 · Cited by 1
Antileishmanial activity of auranofin against Leishmania major in vitro
Delavari, M., Olya, M. M., Arbabi, M., Rasti, S., Hooshyar, H., & Salimian, M. (2022) · International Archives of Health Sciences · doi:10.4103/iahs.iahs_77_21 · Cited by 1
García-Barbazán, I., García‐Rodas, R., Sachse, M., Luque, D., Megı́as, D., & Zaragoza, Ó. (2022) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2022.04.06.487428 · Cited by 1
Repurposing FDA approved drugs against the human fungal pathogen, Candida
Kim, K. S., & Martchenko, M. (2015)
Glory, R., & Amandeep, K. (2016) · Spectrum Research Repository (Concordia University)
Molecular Targets for Anticandidal Chemotherapy
Milewski, S. (2017) · Springer eBooks · doi:10.1007/978-3-319-50409-4_21
The social marketing of contraceptives in Mexico.
Macorra, L. D. L. (1980) · PubMed
Singh, U., & Kangussu-Marcolino, M. M. (2018) · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature · doi:10.3410/f.732876734.793546614
Ansari, A., Kumar, D., Rai, N., & Kumar, N. (2024) · Environment Conservation Journal · doi:10.36953/ecj.27762844
Effectiveness of drug repurposing approach against Candida isolates
Ansari, A., Saini, M. K., Kumar, D., Rai, N., & Kumar, N. (2024) · Environment Conservation Journal · doi:10.36953/ecj.30540224
Rodríguez, A. V., Rodrigues, C. F., Ramage, G., & Lopez-Ribot, J. L. (2025) · Springer series on biofilms · doi:10.1007/978-3-031-93315-8_12
Self-citationFagbemi, A. A., Babalola, C. P., Kwasi, D. A., Akinlabi, O. C., Kotila, O. A., & Okeke, I. N. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.02.26.707623
Rodríguez, A. V., & Lopez-Ribot, J. L. (2026) · Journal of Fungi · doi:10.3390/jof12080581
Self-citationCascading damage to Candida albicans cells through thioredoxin reductase loss
Qi, W., Roy, U., Cai, C., Acosta‐Zaldívar, M., Mascio, J., Asara, J. M., Fierro, J. F., Andrés, M. T. A., Sun, L., & Köhler, J. R. (2026) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2615451123 · Cited by 1
Investigation of naturally derived compounds with antibiofilm activity against Candida albicans
Guimarães, C. D. R. E., de Freitas, H. F., de Souza, T. A., Abreu, L. S., Tavares, J. F., & Barros, T. F. (2026) · Natural Product Research · doi:10.1080/14786419.2026.2738216
Metadata
- Authors
- Siles, S. A., Srinivasan, A., Pierce, C. G., Lopez-Ribot, J. L., & Ramasubramanian, A. K.
- Affiliations
- The University of Texas at San Antonio (US)
- Departments of Biology, The University of Texas at San Antonio, San Antonio, Texas, USA
- Venue
- Antimicrobial Agents and Chemotherapy
- Publisher
- American Society for Microbiology
- Published
- 2013-08
- Volume
- 57
- Issue
- 8
- Pages
- 3681-3687
- ISSN
- 0066-4804 (ISSN-L)
- 1098-6596
- PMC
- PMC3719724
- OpenAlex
- W2171146043
- Cited by
- 120
- References
- 47
- Citations by year
- 2026: 4 · 2025: 5 · 2024: 5 · 2023: 10 · 2022: 11 · 2021: 10 · 2020: 16 · 2019: 10 · 2018: 14 · 2017: 6 · 2016: 9 · 2015: 14 · 2014: 3 · 2013: 2
- FWCI
- 6.78
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Antimicrobial Agents and Chemotherapy (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- U.S. Department of Defense
- San Antonio Area Foundation
- National Heart, Lung, and Blood Institute (SC1HL112629)
- National Institute of Dental and Craniofacial Research (R01DE023510)
- Army Research Office
- Topics
- Health Sciences › Medicine › Infectious Diseases › Antifungal resistance and susceptibility
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Bacterial biofilms and quorum sensing
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Fungal and yeast genetics research
- Keywords
- Candida albicans, biofilm formation, antibiofilm agents, antifungal drug repurposing, FDA-approved drugs, Prestwick Chemical Library, high-content screening, drug discovery, systemic fungal infection
- MeSH terms
- Amphotericin B, Antifungal Agents, Benzethonium, Candida albicans, Dimethyl Sulfoxide, Disinfectants, Dose-Response Relationship, Drug, Microbial Sensitivity Tests, Biofilms, Microbial Viability, Small Molecule Libraries, High-Throughput Screening Assays
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
